We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 94
Most popular |Most recent

New Regulations Modernize Payment for Clinical Laboratory Tests in the United States

USA - June 27 2016 On June 23, the Centers for Medicare & Medicaid Services (CMS) published its long-awaited final rule (Final Rule) creating a market-based...

Richard D. Raskin, Barbara Cammarata.

Sidley Global Pricing newsletter - V4 2016

USA, Netherlands, Australia, Spain, Sweden, United Kingdom, Belgium, Canada, China, European Union, France, Germany, India - January 27 2016 The Australian Pharmaceutical Benefits Pricing Authority (PBPA) ceased operations on April 1, 2014, in a move by the government to improve drug...

Lei Li, Trevor L. Wear, William A. Sarraille, Maarten Meulenbelt.

The Wait Is Over: CMS Issues Final Rule With Comment Period Addressing Medicaid Drug Reimbursement and Rebates

USA - January 23 2016 On January 21, 2016, the Centers for Medicare and Medicaid Services (CMS or the Agency) released an advance-print copy of the long-awaited final rule...

Trevor L. Wear, William A. Sarraille, Meenakshi Datta, Stephanie P. Hales.

OIG’s annual Work Plan targets drug pricing and data protection issues

USA - November 10 2015 The Department of Health and Human Services (HHS) Office of Inspector General (OIG) has released its Work Plan for fiscal year 2016. The items...

Paul E. Kalb, William A. Sarraille, Brenna E. Jenny.

HRSA releases anticipated 340B Proposed Rule on ceiling price calculations and CMPs

USA - June 19 2015 A new 340B Proposed Rule, released on June 16 by the Health Resources and Services Administration (HRSA), addresses standards and requirements for...

Kaitlyn Findley, William A. Sarraille, Stephanie P. Hales.